<DOC>
	<DOCNO>NCT02233231</DOCNO>
	<brief_summary>This study describe change inflammation airway asthmatic smoke cessation steroid treatment .</brief_summary>
	<brief_title>Smoking Young Asthmatics : Change Inflammation During Tobacco Cessation Steroid Treatment</brief_title>
	<detailed_description>84 smoking asthmatic include . 50 % treated varenicline 50 % placebo tablet 12 week . All treat inhaled steroid 12 week . Study period : About 26 week include asthma screening . 4 visit perform . Inflammation describe sputum induction , several pulmonary medical test perform , include NO , methacholine , spirometry , CO , blood sample , skin prick test asthma questionaires .</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Varenicline</mesh_term>
	<criteria>Asthmatic symptom last year least one criterion : 1. current FEV1increase minimum 12 % b2agonist , 2. positiv Methacholintest , 3 . Daytoday FEV1variation least 20 % twoweek period . 4 . Positive mannitol test . Furthermore , inclusion criterion : At least 10 packyears At least 10 cigarette per day within last year Age 1840 year 1 . Asthmatics treat inhaled corticosteroid ( ICS ) , systemic corticosteroid , leukotrienantagonists ( LTA ) , longlasting b2agonists , anticholinergic medicine varenicline within last 3 month 2 . Lower respiratory tract infection , include pneumonia , within last 6 week . 3 . Patients suffer chronic respiratory disease asthma , sarcoidosis COPD also exclude . 4 . Pregnant nursing woman exclude well woman plan pregnancy study period . 5 . A history allergy towards study drug lead exclusion . Patients study period develop low respiratory infection due severe uncontrolled asthma receive treatment list type medicine exclude . Patients diagnose chronic respiratory disease asthma study period also exclude , well patient study period require asthma medicine plan study medication . Any participant wish leave study , reason , include unacceptable sideeffects , study period exclude , well anyone want withdraw record data project study period end . In case unacceptable sideeffects varenicline result immediate cessation treatment drug , participant continue visit unchanged , he/she exclude calculation tobacco cessation succesrate . However , varenicline cessation 4 week treatment start varenicline result exclusion replacement participant . Cessation treatment budesonide result exclusion rest study . The person replace . The data record participant last visit cessation use . Allergic reaction towards study drug result immediate cessation drug , possible exclusion , describe .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>